Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 11/20 | 0.57 |
| ▸ | CNR2 | P34972 | 11/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | ABHD12 | Q8N2K0 | 3/20 | 0.43 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | LDHA | P00338 | 1/20 | 0.43 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.43 |
| ▸ | GPR183 | P32249 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.43 |
| ▸ | GPR18 | Q14330 | 1/20 | 0.43 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.43 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31103607 | 1.00 | CNR1 (0.57) | CNR1CNR2OPRM1ACE2ABHD12 | |
| SCHEMBL26112343 | 0.84 | OPRM1 (0.62) | CNR1CNR2OPRM1ABHD12ABHD6 | |
| SCHEMBL20911820 | 0.84 | OPRM1 (0.62) | CNR1CNR2OPRM1ABHD12ABHD6 | |
| SCHEMBL26136617 | 0.84 | OPRM1 (0.62) | CNR1CNR2OPRM1ABHD12ABHD6 | |
| SCHEMBL23627717 | 0.84 | OPRM1 (0.62) | CNR1CNR2OPRM1ABHD12ABHD6 | |
| SCHEMBL23765201 | 0.84 | OPRM1 (0.62) | CNR1CNR2OPRM1ABHD12ABHD6 | |
| SCHEMBL29351653 | 0.84 | OPRM1 (0.62) | CNR1CNR2OPRM1ABHD12ABHD6 | |
| SCHEMBL13932166 | 0.84 | OPRM1 (0.62) | CNR1CNR2OPRM1ABHD12ABHD6 | |
| SCHEMBL13214152 | 0.84 | OPRM1 (0.62) | CNR1CNR2OPRM1ABHD12ABHD6 | |
| SCHEMBL17250067 | 0.83 | CNR1 (0.56) | CNR1CNR2OPRM1ABHD12ABHD6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629384-B2 | Use of 8,9-dihydrocannabidiol compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-19 | — | — | US | disclosed |
| US-20250152520-A2 | USE OF 8,9- DIHYDROCANNABIDIOL COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-05-15 | — | — | US | disclosed |
| EP-3935037-A1 | USE OF 8,9-DIHYDROCANNABIDIOL COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-01-12 | — | — | EP | disclosed |
| WO-2020185661-A1 | USE OF 8,9-DIHYDROCANNABIDIOL COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250152520-A2 | USE OF 8,9- DIHYDROCANNABIDIOL COMPOUNDS | CNR2, CACNA1B, CNR1 | CNR1 3/4885CNR2 1/4885OPRM1 2579/4885 |
| US-12629384-B2 | Use of 8,9-dihydrocannabidiol compounds | CNR2, CNR1, CYP2J2 | CNR1 2/4885CNR2 1/4885OPRM1 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.